Clinical Trial Update: Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ceftaroline for hematogenously acquired Staphylococcus aureus osteomyelitis in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Infection
• Hematogenously Acquired Staphylococcus Aureus Osteomyelitis
• Osteomyelitis

Drugs mentioned

• ceftaroline (ceftaroline fosamil)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hematogenously Acquired Staphylococcus Aureus Osteomyelitis, Bone Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-02